查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲微阵列分析市场：按产品、类型、应用、最终用户、国家 - 分析和预测（2023-2033）
市场调查报告书
商品编码
1594216

欧洲微阵列分析市场：按产品、类型、应用、最终用户、国家 - 分析和预测（2023-2033）

Europe Microarray Analysis Market: Focus on Product, Type, Application, End User, and Country Level Analysis - Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 79 Pages | 商品交期: 1-5个工作天内

价格

2023年欧洲微阵列分析市场规模为16.902亿美元。预计2033年市场规模将达32.36亿美元，2023-2033年预测期间复合年增长率为6.71%。欧洲微阵列分析市场的成长是由基因组学计划数量的增加、药物筛检中微阵列技术的使用增加以及癌症筛检中的日益采用所推动的。该市场涵盖各种消耗品、设备、软体和服务，支持该全部区域基因组学和个人化医疗的进步。

主要市场统计数据
预测期 2023-2033
2023年评估 16.902 亿美元
2033 年预测 32.36亿美元
复合年增长率 6.71%

由于生物技术、个人化医疗和基因组学研究的市场开拓，欧洲微阵列分析市场正在显着成长。药物发现、疾病诊断和生物标记鑑定都在很大程度上依赖微阵列技术，该技术能够分析基因表现、基因突变和其他分子资料。微阵列分析的使用正在许多行业中迅速扩展，包括医疗保健、製药和农业，其中欧洲处于基因组研究和创新的前沿。

该行业正在受到越来越多的基因组学计划和倡议的推动，这些计画和倡议寻求高通量、负担得起的基因分析工具。此外，由于微阵列在药物开发和癌症筛检，该市场正在开拓，这使得早期检测、个人化治疗策略和治疗标靶的识别成为可能。

耗材、设备、软体和服务是关键市场类别，对于临床和研究环境中微阵列分析的成功至关重要。欧洲市场的领先公司正在专注于开发提高扩充性、准确性和灵敏度的技术。随着分子诊断和精准医疗需求的不断增长，欧洲微阵列分析市场预计将进一步成长，推动生物技术和医疗保健的发展。

该报告考察了欧洲微阵列分析市场，并提供了市场概况，包括按产品、类型、应用、最终用户、国家和参与市场的公司概况分類的趋势。

目录

执行摘要

第一章 市场

  • 趋势：当前和未来的影响评估
  • 生态系概观：微阵列分析市场
  • 研究发展回顾
  • 监管状况
  • 全球重大事件的影响分析 - COVID-19
  • 价格分析
  • 市场动态概览

第二章 区域

  • 区域概况
  • 促进因素和抑制因素
  • 欧洲

第三章市场－竞争基准化分析与公司概况

  • 未来展望
  • 竞争力评估
    • F. Hoffmann-La Roche Ltd.
    • Merck KGaA

第四章调查方法

Product Code: BHP2397SS

Introduction to Europe Microarray Analysis Market

The Europe microarray analysis market was valued at $1,690.2 million in 2023 and is expected to reach $3,236.0 million by 2033, growing at a CAGR of 6.71% during the forecast period 2023-2033. This growth in the Europe microarray analysis market is driven by the increasing number of genomics projects, the growing use of microarray technology in drug screening, and its expanding adoption in cancer screening. The market encompasses a wide range of consumables, instruments, software, and services, supporting advancements in genomics and personalized medicine across the region.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$1,690.2 Million
2033 Forecast$3,236.0 Million
CAGR6.71%

The market for microarray analysis in Europe has grown significantly due to developments in biotechnology, personalized medicine, and genomics research. Drug discovery, disease diagnosis, and biomarker identification all heavily rely on microarray technology, which makes it possible to analyze gene expression, genetic variation, and other molecular data. The use of microarray analysis is spreading quickly across a number of industries, including healthcare, pharmaceuticals, and agriculture, as Europe remains at the forefront of genomic research and innovation.

The growing number of genomics projects and efforts, which call for high-throughput and reasonably priced genetic analysis tools, is driving the industry. Additionally, the market is expanding because to the increasing use of microarrays in drug development and cancer screening, which allow for early detection, individualized treatment strategies, and the identification of therapeutic targets.

Consumables, instruments, software, and services are important market categories that are essential to the success of microarray analysis in clinical and research settings. Leading firms in the European market are concentrating on developing technologies to increase scalability, precision, and sensitivity. With the growing need for molecular diagnostics and precision medicine, the European microarray analysis market is expected to grow further, propelling biotechnology and healthcare developments.

Market Segmentation:

Segmentation 1: by Product Type

  • Instruments
  • Consumables
  • Software and Services

Segmentation 2: by Type

  • DNA Microarray
  • Protein Microarray
  • Other Microarray

Segmentation 3: by Application

  • Clinical Diagnostics
  • Drug Discovery and Translational Research
  • Others

Segmentation 4: by End User

  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others

Segmentation 5: by Country

  • France
  • Germany
  • Italy
  • Spain
  • U.K.
  • Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The Europe microarray analysis market (by product) has been segmented into detailed segments, including different types of consumables, such as arrays, kits and reagents, and accessories as well as instruments, and software and services.

Growth/Marketing Strategy: A strategic growth and marketing approach for the microarray analysis market would involve positioning the company as a leader in innovative solutions that address the evolving needs of researchers, clinicians, and pharmaceutical partners. This would entail leveraging technological advancements to develop cutting-edge products with enhanced sensitivity, specificity, and scalability, while also investing in comprehensive customer support, training programs, and collaborative partnerships to foster customer loyalty and drive market penetration.

Competitive Strategy: Key players in the Europe microarray analysis market have been focusing on innovation, differentiation, and strategic collaborations to gain a competitive edge. By investing in research and development, companies can develop novel detection methods, improve assay sensitivity, and expand application areas. Differentiation through the development of proprietary technologies, customizable solutions, and value-added services can help companies stand out in a crowded market. to strengthen market positions, acquire new technologies, and broaden product portfolios.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Key Trends
      • 1.1.1.1 Technological Advancements in Microarray Analysis
      • 1.1.1.2 Developing Focus on Automation and Artificial Intelligence Integration in Microarray Analysis
  • 1.2 Ecosystem Overview: Microarray Analysis Market
    • 1.2.1 Value Addition Across the Process
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Impact Analysis for Key Global Events - COVID-19
  • 1.6 Pricing Analysis
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
      • 1.7.1.1 Rising Numbers of Genomics Projects Fuelling the Growth of Microarray Analysis Market
      • 1.7.1.2 Use of Microarray Technology in Drug Discovery
      • 1.7.1.3 Increasing Adoption of Microarray Technology in Cancer Screening
    • 1.7.2 Market Restraints
      • 1.7.2.1 Competition from Alternative Technologies such as NGS
      • 1.7.2.2 Challenges in Complex Data Analysis due to Lack of Skilled Professionals
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Novel Biomarker Discovery with the Use of Microarray Technology
      • 1.7.3.2 Utilization of Predictive Genomics for the Development of Personalized Medicines

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Germany
    • 2.3.5 U.K.
    • 2.3.6 France
    • 2.3.7 Italy
    • 2.3.8 Spain
    • 2.3.9 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Competitive Assessment
    • 3.2.1 F. Hoffmann-La Roche Ltd.
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/Product Portfolio
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Key Personnel
      • 3.2.1.5 Analyst View
    • 3.2.2 Merck KGaA
      • 3.2.2.1 Overview
      • 3.2.2.2 Top Products/Product Portfolio
      • 3.2.2.3 Top Competitors
      • 3.2.2.4 Key Personnel
      • 3.2.2.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Microarray Analysis Market, $Million, 2023, 2026, and 2033
  • Figure 2: Microarray Analysis Market (by Region), $Million, 2022, 2026, and 2033
  • Figure 3: Europe Microarray Analysis Market (by Application), $Million, 2022, 2026, and 2033
  • Figure 4: Europe Microarray Analysis Market (by Type), $Million, 2022, 2026, and 2033
  • Figure 5: Europe Microarray Analysis Market (by Product), $Million, 2022, 2026, and 2033
  • Figure 6: Europe Microarray Analysis Market (by End User), $Million, 2022, 2026, and 2033
  • Figure 7: Key Industrial Developments in Microarray Analysis Market, 2023
  • Figure 8: Opportunities in Genetic Research through AI and Automation
  • Figure 9: Ecosystem Overview of Microarray Analysis Market and Operational Challenges
  • Figure 10: Microarray Analysis Market, Patent Analysis (by Country), January 2020-December 2023
  • Figure 11: Microarray Analysis Market, Patent Analysis (by Year), January 2020-December 2023
  • Figure 12: Examples of the Key Initiative Related to Genomics
  • Figure 13: Applications of Microarray Analysis Technology in Drug Discovery
  • Figure 14: Microarray vs. RNA Sequencing, NGS, and PCR
  • Figure 15: Pitfalls in Data Analysis due to Lack of Skilled Professionals
  • Figure 16: Key Initiatives Focused on Pharmacogenomics to Improve the Landscape of Precision Medicine
  • Figure 17: Precision Medicine vs. Other Medicine
  • Figure 18: Germany Microarray Analysis Market, $Million, 2022-2033
  • Figure 19: U.K. Microarray Analysis Market, $Million, 2022-2033
  • Figure 20: France Microarray Analysis Market, $Million, 2022-2033
  • Figure 21: Italy Microarray Analysis Market, $Million, 2022-2033
  • Figure 22: Spain Microarray Analysis Market, $Million, 2022-2033
  • Figure 23: Strategic Initiatives, 2021-2024
  • Figure 24: Share of Strategic Initiatives, 2021-2024
  • Figure 25: Data Triangulation
  • Figure 26: Top-Down and Bottom-Up Approach
  • Figure 27: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Microarray Analysis Market, Opportunities
  • Table 3: Key Companies and Technological Advancements, 2022-2023
  • Table 4: Pricing Analysis of Microarray Analysis Products (Instruments and Consumables)
  • Table 5: Impact Analysis of Market Navigating Factors, 2022-2033
  • Table 6: Examples of Arrays Used in Cancer Screening
  • Table 7: Microarray Analysis Market (by Region), $Million, 2022-2033
  • Table 8: Europe Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 9: Europe Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 10: Europe Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 11: Europe Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 12: Germany Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 13: Germany Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 14: Germany Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 15: Germany Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 16: U.K. Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 17: U.K. Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 18: U.K. Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 19: U.K. Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 20: France Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 21: France Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 22: France Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 23: France Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 24: Italy Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 25: Italy Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 26: Italy Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 27: Italy Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 28: Spain Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 29: Spain Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 30: Spain Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 31: Spain Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 32: Rest-of-Europe Microarray Analysis Market, $Million, 2022-2033
  • Table 33: Rest-of-Europe Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 34: Rest-of-Europe Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 35: Rest-of-Europe Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 36: Rest-of-Europe Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 37: Company Market Share, 2022